Ran Friedman

Ran Friedman is a Professor of Chemistry at Linnaeus University, specializing in computational chemistry and biochemistry. He teaches medicinal and physical chemistry to students in nutritional sciences, pharmacy, and advanced programs. His research focuses on computational studies of biomolecules, particularly in cancer-related mechanisms, drug resistance, and protein-ion interactions. He leads the Computational Chemistry and Biochemistry Group and contributes to the Linnaeus University Centre for Biomaterials Chemistry.

Research interests include using molecular dynamics simulations, quantum chemistry, and stochastic modeling to understand disease mechanisms, such as amyloid aggregation and cancer drug resistance. Current projects explore resistance mutations in leukemia and the development of inhibitors targeting kinases like FLT3 and Abl1. His work integrates computational methods with biological systems to address clinical challenges in oncology and drug design.

Publications highlight advancements in kinase catalytic mechanisms, binding energy calculations, and drug resistance models. Collaborations span computational biology, materials science, and medicinal chemistry. His research emphasizes translating computational insights into therapeutic strategies for diseases like leukemia and chronic myeloid leukemia.